(CRISPR Therapeutics AG)

	CRSP latest price $15.2000 (-0.78%) ($15.0000 - $15.5000) on Fri. Nov. 4, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	5.67% (three month average)
RSI	50
Latest Price	$15.2000(-0.78%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	CRSP declines -1.8% a day on average for past five trading days.
Market Behavior	Normal for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support CRSP advance at 0% a week (0% probability)   ARKG(60%)    IBB(56%)    XBI(54%)    ARKK(53%)    IWO(50%)
Factors Impacting CRSP price	CRSP will decline at least -2.835% in a week (0% probabilities).   VIXM(-12%)    UUP(-5%)    TLT(-4%)    SHY(-4%)    IPO(-3%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-2.835% (StdDev 5.67%)
Hourly BBV	0 ()
Intraday Trend	-1.9%

5 Day Moving Average	$16.42(-7.43%)
10 Day Moving Average	$15.82(-3.92%)
20 Day Moving Average	$0(INF%)
To recent high	-16.7%
To recent low	10%
Market Cap	$951m

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.

getNextHourMoveProbability failed